Piroxantrone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePiroxantrone
Drug Alias Name吡咯蒽醌piroxantronumpiroxantrona吡罗蒽醌Oxantrazole +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsEndometrial NeoplasmsStomach NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsEndometrial NeoplasmsStomach NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG